eFHS Messaging Trial
Completed · Not applicable
Conditions studied: Cardiovascular Diseases
In brief
In this research the investigators will develop and test an innovative scalable mobile health and digital cardiovascular monitoring system within a longitudinal deeply characterized cohort with three components: 1) smartphone application (app) designed to promote adherence, integrate digital and mHealth information, and facilitate communication with participants and researchers; 2) smartwatch activity monitoring using the Apple iWatch; and 3) home blood pressure (BP) monitoring using the Withings blood pressure device. The objective of the messaging trial is to test the effect of messaging strategies on improving participants' long-term use of and engagement with our selected mobile health technologies and on increasing response rate of survey data collection.
Key facts
- Study ID
- NCT03516019
- Run by
- Boston University
- People needed
- 650
- Starts
- 2018-05-19
- Expected to finish
- 2019-03-23
- Last updated by the study team
- 2021-02-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- Participants who do not meet the inclusion criteria
Where it is running
- Framingham Heart Study — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.